SmithKline OTC sales jump 68% in second quarter with Panadol contribution.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE BEECHAM OTC SALES JUMP 68% IN SECOND QUARTER boosted by the contribution of Sterling Winthrop's international OTC business led by Panadol. SmithKline Beecham's OTC sales for the quarter were [pound]254 mil., or $403.8 mil., based on the currency translation of [pound]=$1.59. The company noted in a July 25 release that the inclusion of the Sterling products led to a 41% sales gain in Europe and 118% sales growth in international markets